(Q73912582)
Statements
Phase II double-blind, dose-ranging clinical evaluation of gadobenate dimeglumine in focal liver lesions: with analysis of liver and kidney signal change on early and delayed imaging (English)
V M Runge
scientific article published on 01 June 2000
No description defined